| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2B | $0.9B | $0.7B | $0.9B | $1.0B | $0.7B | $0.5B | $0.6B |
| Cost of Revenue | — | — | — | — | — | $2.0B | $2.0B | $2.2B |
| Gross Profit | — | $0.3B | $0.2B | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Operating Income | $1.0B | $0.8B | $0.8B | $0.9B | $0.7B | $0.2B | $0.2B | $0.2B |
| Net Income | $0.8B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $6.99 | $1.23 | $1.07 | $2.50 | $2.24 | $0.65 | $0.50 | $0.47 |
| EPS (Diluted) | $6.86 | $1.21 | $1.05 | $2.46 | $2.21 | $0.64 | $0.50 | $0.47 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.7B | $3.3B | $2.8B | $2.2B | $1.7B | $1.5B | $1.4B | $1.4B |
| Current Assets | $2.4B | $2.0B | $2.0B | $1.5B | $1.0B | $0.8B | $0.7B | $0.7B |
| Cash & Equivalents | $1.4B | $1.0B | $1.2B | $0.5B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $0.5B | $0.5B | $0.4B | $0.4B | $0.5B | $0.7B | $0.7B | $0.8B |
| Current Liabilities | $0.4B | $0.4B | $0.3B | $0.3B | $0.4B | $0.3B | $0.2B | $0.2B |
| Stockholders' Equity | $3.2B | $2.8B | $2.3B | $1.8B | $1.2B | $0.8B | $0.6B | $0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.6B | $0.7B | $0.7B | $0.3B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.0B | $-0.6B | $0.1B | $-0.2B | $0.0B | $-0.1B | $-0.0B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.2B | $-0.1B | $-0.1B | $-0.4B | $-0.1B | $-0.1B | $-0.0B |